Skip to content

Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries

Comparison of oxycodone and naproxen in pain control of soft tissue injuries

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201112208104N3
Enrollment
150
Registered
2012-08-31
Start date
2012-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

soft tissue injuries. musculoskeletal system and connective tissue

Interventions

Intervention 1: First group will receive 250 mg Naproxen. Intervention 2: Second group receive 10 mg Oxycodone.
Treatment - Drugs
First group will receive 250 mg Naproxen
Second group receive 10 mg Oxycodone

Sponsors

Vice Chancellor of Research; Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criterion: patients above 18 years old with soft tissue injuries. Exclusion criteria: contraindications for opioids and NSAIDs and presence of fracture.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain control. Timepoint: 0, 30, 60 minutes after treatment. Method of measurement: Numeric Rating Scale.

Secondary

MeasureTime frame
Presence of side effects. Timepoint: 30 and 60 minutes after treatment. Method of measurement: Patient monitoring.;Need for follow up analgesic. Timepoint: First 24 hours after discharge. Method of measurement: Telephone follow up.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Amin Zare

Tehran University of Medical Sciences

mazare74@yahoo.com+98 21 6652 5327

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026